Long, J., Dai, W., Zheng, Y., & Zhao, S. (2019). miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Mol Med.
Citação norma ChicagoLong, Jun-Ke, Wen Dai, Ya-Wen Zheng, e Shui-Ping Zhao. "MiR-122 Promotes Hepatic Lipogenesis Via Inhibiting the LKB1/AMPK Pathway By Targeting Sirt1 in Non-alcoholic Fatty Liver Disease." Mol Med 2019.
Citação norma MLALong, Jun-Ke, Wen Dai, Ya-Wen Zheng, e Shui-Ping Zhao. "MiR-122 Promotes Hepatic Lipogenesis Via Inhibiting the LKB1/AMPK Pathway By Targeting Sirt1 in Non-alcoholic Fatty Liver Disease." Mol Med 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.